Invert, a leading AI bioprocess software company, has unveiled Invert Assist, an AI-powered natural language interface that enables scientists to analyze data and model processes in real time.
Designed for biopharmaceutical manufacturing, the system allows users to interact with complex datasets through simple, chat-based commands—making it easier to identify process trends, perform data analysis, and generate predictive models without needing extensive programming expertise.
Unlike general-purpose AI tools, Invert Assist is purpose-built for regulated biomanufacturing environments. It executes traceable and verifiable Python code, ensuring scientific accuracy, auditability, and compliance with industry standards. This focus on reliability and transparency makes the platform suitable for use in Good Manufacturing Practice (GMP) settings where reproducibility and data integrity are essential.
In benchmark tests, Invert Assist demonstrated a significant performance edge over general AI models such as ChatGPT. It scored more than twice as high in bioprocess optimization recommendations, highlighting its specialization and effectiveness for domain-specific applications.
By combining conversational AI with rigorous scientific validation, Invert Assist empowers bioprocess scientists and engineers to accelerate development cycles, improve process control, and enhance decision-making across research and manufacturing workflows. The launch underscores Invert’s mission to bridge the gap between data science and bioprocess operations—helping the life sciences industry move toward more intelligent and AI-driven production systems that maintain the highest standards of accuracy and compliance.
KEY QUOTE:
“We’ve built Invert to close the gap between data and action. Our new AI offering transforms bioprocess data into actionable insights without the user needing to write code. What once took months, now takes seconds.”
Martin T. Permin, CEO and Founder, Invert
